156
Participants
Start Date
September 14, 2020
Primary Completion Date
February 26, 2021
Study Completion Date
March 22, 2021
Remdesivir (RDV)
Administered as an aerosolized solution
Placebo
Administered as an aerosolized solution
Research in Miami, Inc., Hialeah
Evolution Clinical Trials, Inc., Hialeah Gardens
Optimus U Corporation, Miami
L & C Professional Medical Research Institute, Miami
Westchester Research Center at Westchester General Hospital, Miami
IMIC Inc, Palmetto Bay
Integrity Clinical Research, LLC, Doral
MedBio Trials, Miami
Nuovida Research Center, Corp, Miami
Holy Cross Hospital, Fort Lauderdale
Triple O Research Institute, PA, West Palm Beach
Bradenton Research Center, Inc., Bradenton
STAT Research, Vandalia
CTU Covid Research Center, New Orleans
DFW Clinical Research, Dallas
Baylor Research Institute, Dallas
PCP for Life-Tidwell, Houston
Inquest Clinical Research, Baytown
Family Care Research, Boise
The Institute for Liver Health, Mesa
The Institute for Liver Health, Tucson
Cedars-Sinai Medical Center, Los Angeles
Aurora FDRC Inc., Costa Mesa
Elevated Health, Huntington Beach
Western Clinical Research, Placentia
Franco Felizarta, MD, Bakersfield
UC Davis Health/Medical Center, Sacramento
Providence Regional Medical Center Everett, Everett
Lead Sponsor
Gilead Sciences
INDUSTRY